Industry News
Prescient MD resigns
Dr Robert Crombie, the managing director of oncology company Prescient Therapeutics, has resigned in order to focus on other business opportunities. [ + ]
A rebranding and a new CEO for Merck
Pharmaceutical company Merck has announced a relaunch of its brand identity in order to reflect its transformation into a global science and technology company. [ + ]
ASCVD drug trial terminated due to insufficient efficacy
Eli Lilly and Company (Lilly) will terminate its phase 3 trial of the investigational medicine evacetrapib due to insufficient efficacy. [ + ]
Promega multiplex assay approved by FBI
Promega's PowerPlex Fusion 6C System has been granted approval by the FBI in the United States for use in laboratories that generate DNA records for the National DNA Index System (NDIS). [ + ]
Cynata collaborates on cell therapy for cancer
Cynata Therapeutics will collaborate with Massachusetts General Hospital on the development of modified mesenchymal stem cells (MSCs) to treat cancer. [ + ]
Algae cultivation for biokerosene production
The Technical University of Munich has built a technical facility for algae cultivation at its Ludwig Bölkow Campus in Ottobrunn, south of Munich. The facility will develop efficient processes for producing biokerosene and chemical products from algae. [ + ]
Myelin researcher scores AbbVie Student Poster Award
The 2015 AbbVie Student Poster Awards recognised the important research being carried out by Australian graduate students in areas such as pharmaceutical sciences, disease research, biology and nutritional science. [ + ]
Starving breast cancer cells of nutrients
A research team led by Sydney's Centenary Institute has discovered a significant link between breast cancer and nutrition — one which could lead to a new treatment aimed at 'starving' breast cancer cells. [ + ]
ResMed completes Curative Medical acquisition
ResMed has completed its acquisition of Curative Medical, a provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories to the Chinese market. [ + ]
3D imaging a cancer protein
Scientists have created what is said to be the first 3D image of a key protein known to be involved in the development of blood and other cancers. [ + ]
Lonza's versatile media kits
Recent peer-reviewed publications have highlighted the versatility of Lonza's specialised BulletKit Growth and Differentiation Media. The papers show that the media kits are proving useful for researchers looking to transition from established cell lines to primary cell culture or when co-culturing different cell types. [ + ]
Cancer and blood researchers elected as AAHMS fellows
Three researchers from the Walter and Eliza Hall Institute have been elected as fellows of the Australian Academy of Health and Medical Sciences in recognition of their contributions to Australian medical research. [ + ]
Nanosatellite testing at ANU
A European satellite mission has turned to The Australian National University (ANU) to help test science units for nanosatellites ahead of a mass launch next year. [ + ]
Enhanced ultrasound technology for earlier tumour diagnosis
An Oxford University spin-out has raised £1 million from a Chinese investor to develop an imaging technology which could help doctors detect cancers — particularly prostate and liver tumours. [ + ]
Personalised medicine to treat mental illness
With World Mental Health Day coming up on 10 October, Genomind is encouraging clinicians to utilise genetic testing in order to optimise treatment decisions for mentally ill patients. [ + ]